Clinical Trials Logo

Endovascular clinical trials

View clinical trials related to Endovascular.

Filter by:
  • None
  • Page 1

NCT ID: NCT06352593 Recruiting - Dexmedetomidine Clinical Trials

Intraoperative Dexmedetomidine Infusion in Endovascular Intervention for Aneurysmal Subarachnoid Hemorrhage

Start date: April 6, 2024
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the role of intraoperative dexmedetomidine infusion in endovascular intervention for aneurysmal subarachnoid hemorrhage.

NCT ID: NCT05342038 Withdrawn - Clinical trials for Acute Ischemic Stroke

Study on the Efficacy and Safety of T-02 for the Treatment for Acute Ischemic Stroke

T-02
Start date: April 22, 2022
Phase: N/A
Study type: Interventional

To examine the revascularization efficacy and safety of T-02 and its associated performance characteristics in treatment of appropriately selected subjects experiencing an acute ischemic stroke when the treatment is initiated within 24 hours after last seen well under the current guideline, and to generate hypotheses to be confirmed in subsequent confirmatory clinical investigations

NCT ID: NCT03923387 Completed - Endovascular Clinical Trials

Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device

PANDA
Start date: May 7, 2019
Phase: N/A
Study type: Interventional

To evaluate the safety and effectiveness of MynxGrip, in hemostasis of common femoral artery puncture site, compared with manual compression hemostasis in patients who have undergone diagnostic or interventional endovascular procedures utilizing a 5F, 6F or 7F procedural sheath.

NCT ID: NCT00118573 Terminated - Clinical trials for Aortic Aneurysm, Abdominal

Comparison of Surveillance Versus Aortic Endografting for Small Aneurysm Repair

CAESAR
Start date: September 2004
Phase: Phase 4
Study type: Interventional

Objective of the present study is to compare endovascular repair versus surveillance and, eventually delay treatment in patients with small abdominal aortic aneurysms (AAA), with respect to patient survival, AAA rupture and AAA related death risks.